235 related articles for article (PubMed ID: 36481799)
1. Prospects for gene replacement therapies in amyotrophic lateral sclerosis.
Giovannelli I; Higginbottom A; Kirby J; Azzouz M; Shaw PJ
Nat Rev Neurol; 2023 Jan; 19(1):39-52. PubMed ID: 36481799
[TBL] [Abstract][Full Text] [Related]
2. [Gene Therapies in Motor Neuron Diseases ALS and SMA].
Günther R
Fortschr Neurol Psychiatr; 2023 Apr; 91(4):153-163. PubMed ID: 36822211
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives.
Lejman J; Panuciak K; Nowicka E; Mastalerczyk A; Wojciechowska K; Lejman M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674643
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic news in ALS.
Corcia P; Beltran S; Bakkouche SE; Couratier P
Rev Neurol (Paris); 2021 May; 177(5):544-549. PubMed ID: 33781562
[TBL] [Abstract][Full Text] [Related]
5. Current developments in gene therapy for amyotrophic lateral sclerosis.
Scarrott JM; Herranz-Martín S; Alrafiah AR; Shaw PJ; Azzouz M
Expert Opin Biol Ther; 2015 Jul; 15(7):935-47. PubMed ID: 25959569
[TBL] [Abstract][Full Text] [Related]
6. Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis.
Saini A; Chawla PA
Eur J Neurol; 2024 Feb; 31(2):e16140. PubMed ID: 37975798
[TBL] [Abstract][Full Text] [Related]
7. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
9. Purinergic P2X
Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
[TBL] [Abstract][Full Text] [Related]
10. Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy.
Cappella M; Pradat PF; Querin G; Biferi MG
J Neuromuscul Dis; 2021; 8(1):25-38. PubMed ID: 33074186
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders.
Goutman SA
Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1332-1359. PubMed ID: 28968365
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of amyotrophic lateral sclerosis as broad therapeutic targets for gene therapy applications utilizing adeno-associated viral vectors.
Merjane J; Chung R; Patani R; Lisowski L
Med Res Rev; 2023 Jul; 43(4):829-854. PubMed ID: 36786126
[TBL] [Abstract][Full Text] [Related]
13. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
Yousefian-Jazi A; Seol Y; Kim J; Ryu HL; Lee J; Ryu H
Cells; 2020 Dec; 9(12):. PubMed ID: 33333804
[TBL] [Abstract][Full Text] [Related]
16. Research advances in amyotrophic lateral sclerosis, 2009 to 2010.
Traub R; Mitsumoto H; Rowland LP
Curr Neurol Neurosci Rep; 2011 Feb; 11(1):67-77. PubMed ID: 21080240
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights and therapeutic targets in amyotrophic lateral sclerosis.
Tripathi VB; Al-Chalabi A
CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):11-9. PubMed ID: 18289027
[TBL] [Abstract][Full Text] [Related]
18. Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.
Bagyinszky E; Hulme J; An SSA
Cells; 2023 Jul; 12(15):. PubMed ID: 37566027
[TBL] [Abstract][Full Text] [Related]
19. From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline.
Liscic RM; Alberici A; Cairns NJ; Romano M; Buratti E
Mol Neurodegener; 2020 Jun; 15(1):31. PubMed ID: 32487123
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
Alisky JM; Davidson BL
Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
